97162 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons; Interleukins [IL] IL-4
AFFIBODY-BASED DUAL AFFINITY FUSION PROTEINS AND USES THEREOF
#2METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#3PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
#4METHODS OF TREATING THE EFFECTS OF CYTOKINE STORMS
#5AFFIBODIES, HYDROGELS CONTAINING AFFIBODIES, AND USES THEREOF
#6DUAL SPECIFIC ANTIBODIES
#7METHODS OF MANAGING EOSINOPHILIC ESOPHAGITIS
#8ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#9DUAL SPECIFIC ANTIBODIES
#10IL-4/IL-13 Pathway Inhibitors for Enhanced Efficacy in Treating Cancer
#11INHALER SYSTEM
#12INHALER SYSTEM
#13LABELING OF ANTIBODIES
#14MODULATING THE EFFECTS OF GAMMA-C-CYTOKINE SIGNALING FOR THE TREATMENT OF ALOPECIA AND ALOPECIA ASSOCIATED DISORDERS
#15METHODS FOR TREATING SYSTEMIC SCLEROSIS
#16TRISPECIFIC AND/OR TRIVALENT BINDING PROTEINS
#17DUAL SPECIFIC ANTIBODIES
#18POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE
#19METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#20ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR
#21FC Variants and Methods for Their Production
#22BISPECIFIC POLYPEPTIDES FOR ENGAGEMENT OF CAR EXPRESSING IMMUNE CELLS WITH ANTIGEN PRESENTING CELLS AND USES THEREOF
#23COMPOSITIONS AND METHODS OF TREATMENT FOR INHIBITING CAPILLARY TUBE REGRESSION
#24MULTISPECIFIC ANTIBODIES AND USES THEREOF
#25METHODS AND COMPOSITIONS UTILIZING IDO1-DEPENDENT VASCULARIZING CELLS FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS INVOLVING NEOVASCULARIZATION
#26COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
#27COMPOSITIONS FOR TREATMENT ALOPECIA AREATA, BIOMARKERS FOR TREATMENT SUCCESS AND, METHODS OF USE THEREOF
#28PRODUCTION OF HETEROMULTIMERIC PROTEINS
#29PHARMACEUTICAL FORMULATIONS OF FCRN INHIBITORS SUITABLE FOR SUBCUTANEOUS ADMINISTRATION
#30Bispecific Caninized Antibodies for Treating Atopic Dermatitis
#31IMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY AND OTHER USES
#32ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#33TYPE 2 CYTOKINES AS PREDICTORS OF DISEASE SEVERITY AND/OR AS THERAPEUTIC TARGETS FOR COVID-19
#34METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R ANTAGONIST
#35METHODS FOR TREATING CHRONIC SPONTANEOUS URTICARIA BY ADMINISTERING AN IL-4R ANTAGONIST
#36SPLIT CH2 DOMAINS
#37METHOD FOR IMPROVING AFFINITY OF ANTI-CYTOKINE ANTIBODY FOR ANTIGEN, METHOD FOR PRODUCING ANTI-CYTOKINE ANTIBODY, AND ANTI-CYTOKINE ANTIBODY
#38Human interleukin-4 receptor alpha antibodies
#39COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING DISEASES OR DISORDERS CAUSED BY OR ASSOCIATED WITH DNASE1 AND/OR DNASE1L3 DEFICIENCY
#40TREATMENT OF PERIODONTITIS VIA INDUCTION OF M2 MACROPHAGES
#41IMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY AND OTHER USES
#42Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
#43Inhaler system
#44ALLERGY THERAPY
#45Treatment of Parkinson's Disease
#46METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY
#47MHC CLASS II MOLECULE-BASED PEPTIDE EXCHANGE SYSTEM AND METHOD
#48METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
#49Trispecific and/or trivalent binding proteins
#50METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR
#51Readily isolated bispecific antibodies with native immunoglobulin format
#52Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof
#53Pyrrolobenzodiazepine-antibody conjugates
#54Combinatorial therapies including implantable damping devices and therapeutic agents for treating a condition and associated systems and methods of use
#55COMPOUNDS AND COMPOSITIONS THAT INHIBIT OR PREVENT LIPOPROTEIN ENTRY INTO THE ENDOTHELIUM
#56METHODS FOR TREATING ACTIVE EOSINOPHILIC ESOPHAGITIS
#57USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
#58METHODS OF USING PHARMACOLOGIC INHIBITORS OF TYPE 2 CYTOKINE SIGNALING TO TREAT OR PREVENT PANCREATIC CANCER
#59Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#60PRODUCTION OF HETEROMULTIMERIC PROTEINS
#61COMPOSITIONS AND METHODS FOR TREATING ALLERGIC DISORDERS
#62Inhaler system
#63Antibody for binding to interleukin 4 receptor
#64Trispecific and/or trivalent binding proteins
#65Antibodies that bind IL-4 and/or IL-13 and their uses
#66Delivering biological drugs to tissues
#67Pharmaceutical formulations of FcRn inhibitors suitable for subcutaneous administration
#68Methods for treating systemic sclerosis
#69Stable Dual Variable Domain Immunoglobulin Protein Formulations
#70METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS
#71Fc variants and methods for their production
#72Highly Versatile Method of Presenting Cyclic Peptide on Protein Structure
#73Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders
#74Inhaler system
#75IL-4/IL-13 pathway inhibitors for enhanced efficacy in treating cancer
#76NOVEL INTERLEUKIN 4 IMMUNOCONJUGATES
#77Antibody for binding to interleukin 4 receptor
#78Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)
#79Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#80DRUG MIXING DEVICE
#81Composition and methods for detecting cancer
#82DRUG MIXING DEVICE
#83DRUG MIXING DEVICE
#84Anti-tumor T cells and their preparation using IL-6
#85Anti-cancer T cells and their preparation using coenzyme A
#86Biomarkers for anti-IL4-IL13 bispecific antibodies
#87PRODUCTION OF HETEROMULTIMERIC PROTEINS
#88ANTIBODY FOR BINDING TO INTERLEUKIN 4 RECEPTOR
#89TREATING RESPIRATORY DISEASES BY TARGETING INTERLEUKIN 4 INDUCED 1 (IL4I1)
#90Therapeutic compositions and methods with cytokine signaling immunomodulators
#91Methods of producing two chain proteins in bacteria
#92Methods for treating active eosinophilic esophagitis
#93Readily isolated bispecific antibodies with native immunoglobulin format
#94PRODUCTION OF HETEROMULTIMERIC PROTEINS
#95Labeling of antibodies
#96Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#97Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
#98Multispecific antibodies facilitating selective light chain pairing
#99COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF CANCER THERAPY
#100Antibodies that bind IL-4 and/or IL-13 and their uses
#101Methods for treating or preventing asthma by administering an IL-4R antagonist
#102Immunogen adherence and method of making and using same
#103Trispecific and/or trivalent binding proteins
#104Novel Treatment for Polycystic Kidney Disease
#105Methods for treating medical conditions by anti-type 2 therapy
#106ANTI-IL4-IL 13 BISPECIFIC ANTIBODIES
#107Uses of a dual V region antibody-like protein
#108Dual specific antibodies
#109Readily isolated bispecific antibodies with native immunoglobulin format
#110ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF
#111ANTIGEN-BINDING CONSTRUCTS
#112Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#113Methods of producing two chain proteins in bacteria
#114Protein in which electrical interaction is introduced within hydrophobic interaction site and preparation method therefor
#115Anti-IL-4/anti-IL-13 bispecific antibody formulations
#116DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF
#117Anti-IL-4/Anti-IL-13 Bispecific Antibody/Polyglutamate Formulations
#118GENETIC AND ENVIRONMENTAL MARKERS TO IDENTIFY INFANTS AT RISK FOR SEVERE LUNG DISEASE
#119Readily isolated bispecific antibodies with native immunoglobulin format
#120STABLE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN PROTEIN FORMULATIONS
#121Fc variants and methods for their production
#122Methods for treating or preventing asthma by administering an IL-4R antagonist
#123Dual variable region antibody-like binding proteins having cross-over binding region orientation
#124Dual variable region antibody-like binding proteins having cross-over binding region orientation
#125USES OF A DUAL V REGION ANTIBODY-LIKE PROTEIN
#126ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#127ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#128ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#129Antibodies that bind IL-4 and/or IL-13 and their uses
#130Antibodies that bind IL-4 and/or IL-13 and their uses
#131ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#132ANTIBODIES THAT BIND IL-4 AND/OR IL-13 AND THEIR USES
#133BINDING DOMAINS
#134Dual Variable Domain Immunoglobulins and Uses Thereof
#135Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
#136Compositions and methods to treat and control tumors
#137SINGLE DOMAIN ANTIBODIES THAT BIND IL-13
#138IL-13 binding protein
#139Antigen-binding proteins
#140Production of heteromultimeric proteins
#141Ligands That Bind Il-4 and/or Il-13
#142ANTIGEN-BINDING CONSTRUCTS
#143BINDING AGENTS DIRECTED AGAINST IL-4 RECEPTOR FOR THE TREATMENT OF TUMORS, INFLAMMATORY AND IMMUNOLOGICAL DISORDERS
#144Readily isolated bispecific antibodies with native immunoglobulin format
#145IMMUNOGLOBULINS
#146ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREATMENT OF CANCER
#147Feline granulocyte macrophage colony stimulating factor proteins
#148HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN IL-4
#149Antibodies that bind IL-4 and/or IL-13 and their uses
#150Fusion Proteins That Contain Natural Junctions
#151Soluble CTLA4 mutant molecules and uses thereof
#152Dual variable domain immunoglobulins and uses thereof
#153ANTIGEN-BINDING CONSTRUCTS
#154Ligands that bind IL-4 and/or IL-13
#155Human monoclonal antibodies against human IL-4
#156Soluble CTLA4 mutant molecules
#157Methods of targeting multiple cytokines
#158High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
#159Compositions and methods to treat and control tumors by loading antigen presenting cells
#160Feline granulocyte macrophage colony stimulating factor nucleic acid molecules
#161Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
#162Feline interferon-alpha proteins
#163Methods for treating cancer and infectious disease by blocking CTLA4-B7 interactions
#164Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
#165Immunogen adherence and method of making and using same